Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aterian Inc (ATER) vs Nuwellis Inc (NUWE) Price & Performance

Aterian IncTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Aterian Inc vs Nuwellis Inc — how do they compare? Aterian Inc trades at $1.17 (market cap $12.98M), while Nuwellis Inc trades at $3.4 (market cap $1.17M). The key difference: Aterian Inc is far larger — about 11.1× Nuwellis Inc's market cap, and Aterian Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

ATERNUWE
Market Cap
$12.98M$1.17M
Sector
Consumer CyclicalTechnology
52-Week High
$1.39$558.26
52-Week Low
$0.54$2.80
Enterprise Value
$13.56M-$636.97K

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aterian Inc

Aterian (ATER) trades at $1.19, up 3.48% with a bullish technical signal despite negative profitability. Recent earnings beats and a pending asset sale that could return $0.85-$1.14 per share provide near-term catalysts. However, the company shows declining revenue from $221M in 2022 to $69M in 2025, with negative net income margins and cash flow challenges.

The outlook hinges on shareholder approval of the brand portfolio sale, offering potential shareholder returns near current price levels. Investment opportunity exists in the asset sale catalyst, but risks include ongoing operational losses, declining revenue, and negative cash flow. Analyst sentiment is evenly split between Buy and Hold recommendations.

Nuwellis Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aterian Inc

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Read more on ATER

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE